Related Experiment Video
Updated: Apr 26, 2026

Reconstruct Human Retinoblastoma In Vitro
Published on: October 11, 2022
Enucleation Refusal for Retinoblastoma: A Global Study
Cristina Olteanu1, Helen Dimaras2,3,4
1a Faculty of Arts & Science , Human Biology Program , and.
Background:
Enucleation (eye removal) is often the only curative treatment for the childhood eye cancer retinoblastoma, yet parental refusal of enucleation commonly contributes to treatment delay and poor survival globally.
Methods:
Physicians who treat retinoblastoma were surveyed to glean underlying reasons for treatment refusal.
Results:
Refusal rates were higher when less time was spent with parents explaining retinoblastoma/enucleation, and where fewer support services were available. Reasons for refusal included parental belief in alternative treatments, culture, and social stigma.
Conclusions:
We suggest strategies to increase parental compliance with enucleation and save the lives of children with retinoblastoma.
Related Concept Videos
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
The Retinoblastoma Gene

